Delcath Systems Stock

Delcath Systems ROCE

The Return on Capital Employed (ROCE) of Delcath Systems (DCTH) as of Aug 1, 2026 is 0.59 %. In the previous year, Return on Capital Employed (ROCE) was -18.05 % — a change of -103.29% (higher).

ROCE

0.59 %

YoY

-103.29%

Last updated:

In 2026, Delcath Systems's return on capital employed (ROCE) was 0.59 %, a -103.29% increase from the -18.05 % ROCE in the previous year.

Access this data via the Eulerpool API

Delcath Systems Stock analysis

What does Delcath Systems do? Delcath Systems Inc is a US-American medical technology company specializing in the development of innovative products for the treatment of various forms of liver cancer. The company was founded in 1988 in New York and is headquartered in Queensbury today. Delcath Systems is one of the most popular companies on Eulerpool.

ROCE Details

Unraveling Delcath Systems's Return on Capital Employed (ROCE)

Delcath Systems's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Delcath Systems's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Delcath Systems's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Delcath Systems’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Delcath Systems stock

Return on Capital Employed (ROCE) of Delcath Systems is 0.59 % in 2026.

Access this data via the Eulerpool API

Profitability — Delcath Systems

All Key Metrics — Delcath Systems